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Background: Dendritic cells localize throughout the body, where they can sense and capture invading pathogens
to induce protective immunity. Hence, harnessing the biology of tissue-resident dendritic cells is fundamental for
the rational design of vaccines against pathogens.
Methods: Herein, we characterized the transcriptomes of four antigen-presenting cell subsets from the human
vagina (Langerhans cells, CD14- and CD14+ dendritic cells, macrophages) by microarray, at both the transcript and
network level, and compared them to those of three skin dendritic cell subsets and blood myeloid dendritic cells.
Results: We found that genomic fingerprints of antigen-presenting cells are significantly influenced by the tissue of
origin as well as by individual subsets. Nonetheless, CD14+ populations from both vagina and skin are geared
towards innate immunity and pro-inflammatory responses, whereas CD14- populations, particularly skin and vaginal
Langerhans cells, and vaginal CD14- dendritic cells, display both Th2-inducing and regulatory phenotypes. We also
identified new phenotypic and functional biomarkers of vaginal antigen-presenting cell subsets.
Conclusions: We provide a transcriptional database of 87 microarray samples spanning eight antigen-presenting
cell populations in the human vagina, skin and blood. Altogether, these data provide molecular information that will
further help characterize human tissue antigen-presenting cell lineages and their functions. Data from this study
can guide the design of mucosal vaccines against sexually transmitted pathogens.Background
Dendritic cells (DCs) are professional antigen-presenting
cells (APCs) that can induce and direct host immune re-
sponses towards immunity or tolerance [1]. DCs dissem-
inate throughout the body, sensing invading pathogens in
various tissues, including the skin [2-4] and mucosa [5-7].
Therefore, defining the biology of tissue-resident DCs is
fundamental for the understanding of tissue-specific im-
mune microenvironments and for the rational design of* Correspondence: sangkono@baylorhealth.edu
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tissues.
Sexually transmitted microbial pathogens, including
viruses and bacteria [8,9], are a major public health bur-
den worldwide. The human vaginal mucosa is the main
entry site of these pathogens and therefore has long
been attractive as a potential site for mounting protect-
ive mucosal immunity. However, the vaginal mucosa, a
site constantly exposed to foreign antigens, is also
thought to be a unique tolerogenic microenvironment
that tightly regulates unwanted immune responses
[10-12]. Nonetheless, the immunology of the human va-
gina remains poorly understood.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of APCs in the human vaginal mucosa, including
Langerhans cells (LCs) in the epithelium, and CD14- DCs,
CD14+ DCs and macrophages (Møs) in the lamina propria
(LP) [5,6]. These mucosal APC subsets display common and
unique functions in directing T-cell responses in vitro [5,6],
as do subsets of DCs isolated from human skin [2-4]. Im-
portantly, DCs can display functional specialization and
plasticity in response to external and internal stimuli [13,14],
which can determine the outcome of host immune re-
sponses. Recent evidence further indicates that these charac-
teristics of DCs can be influenced by tissue-specific physical
and biological factors [15,16]. One can thus hypothesize that
the same DC subsets localized in different tissues could dis-
play distinct functions in response to the same antigens.
These differences may also influence the type of immunity
established in different human anatomical sites. As such,
vaccines delivered to skin DCs can elicit systemic immunity
but are not sufficient to mount mucosal immunity [6,10,17].
Systems biology approaches provide snapshots of gen-
etic, transcriptional and protein networks, enabling the
phenotypic and functional analysis of the immune sys-
tem [18-20]. In this study, we investigated the phenotype
and function of human vaginal DC subsets by micro-
array transcriptional profiling and compared them with
those of DCs from human skin and blood. This study
provides fundamental information for the immunology
of human vaginal mucosa versus skin, which can eventu-
ally guide the rational design of efficacious vaccines
against sexually transmitted pathogens.
Methods
Samples
Vaginal and skin tissues were obtained from female pa-
tients who underwent pelvic or cosmetic surgeries under
protocols approved by the Institutional Review Board of
Baylor Research Institute (Dallas, TX, USA). Informed
consent was waived by the institutional review board
(IRB 008-227) for tissue samples. This study conforms
to the Helsinki Declaration. Patients were not infected
with HIV, hepatitis C virus or tuberculosis and did not
display inflammation in the tissues. Written informed
consent was obtained from healthy female volunteers to
use their blood in this study, and the protocol was ap-
proved by the IRB (IRB 012-200) of Baylor Research
Institute.
Vaginal and skin antigen-presenting cell isolation
Tissue biopsies were cut into 1 cm2 pieces and incubated
in phosphate-buffered saline containing bacterial protease
dispase type 2 (Roche Applied Science, Indianapolis, IN,
USA) and antibiotic/antimycotic solution (Invitrogen,
Carlsbad, CA, USA) overnight at 4°C. Epithelium and LP
were then separated. The LP was cut into smaller pieces(1 to 5 mm2). Epithelial sheets and LP pieces were incu-
bated at 37°C in RPMI 1640 (Invitrogen) supplemented
with HEPES buffer (Invitrogen), antibiotic/antimycotic
(Invitrogen), L-glutamine, nonessential amino acids, so-
dium pyruvate (Sigma Aldrich, St. Louis, MO, USA) and
10% fetal calf serum (HyClone, Logan, UT, USA). After
2 days, the cells that migrated into the medium were
further enriched by Ficoll-sodium diatrizoate gradient
(Lymphocyte Separation Medium, MP Biomedicals, Solon,
OH, USA). Cells were stained with 7-AAD (Biolegend, San
Diego, CA, USA), anti-HLA-DR-AF700 (Biolegend), anti-
Langerin-PE (Beckman Coulter, Brea, CA, USA), anti-
CD1c-FITC (Invitrogen) and CD14-eFluor450 (eBioscience,
San Diego, CA, USA). HLA-DR+ cells were gated and
Langerin+ LCs, CD1c+CD14- DCs, CD1c+CD14+ DCs and
CD1c- CD14+ Møs were sorted by FACS Aria II (BD Bio-
sciences, San Jose, CA, USA) (Figure 1a, b). To purify
HLA-DR- cells, single cell suspensions of epithelium and
LP were mixed and subsequently sorted (Figure 1b). Skin
biopsies were processed similarly. Langerin+ cells from the
epidermis (sLCs; note that cell types prefixed by 's' refer to
skin cells) as well as CD1c+CD14- DCs and CD1c+CD14+
DCs cells from the dermis were sorted by FACS Aria II
(BD Biosciences). As previously described [3], sCD14- DCs
were CD1a+, while sCD14+ DCs were CD1a- and sLCs were
CD1ahigh (Additional file 1).Blood dendritic cell isolation
Peripheral blood mononuclear cells from healthy volunteers
were isolated by density gradient centrifugation using Ficoll-
Paque™ PLUS (GE Healthcare, Stockholm, Sweden). Blood
DCs were enriched from these cells using a Stemcell Pan-
DC kit (Stemcell, Vancouver, BC, Canada) according to the
manufacturer’s protocol. Cells were then stained with Lin-
FITC (BD Biosciences), CD123-PE (Biolegend), CD11c-APC
(BD Biosciences) and HLA-DR-Pacific Orange (Invitrogen).
mDC (Lin-HLA-DR+CD11c+CD123-) were then sorted by
FACS Aria (BD Biosciences) (Figure 1a, b).Immunofluorescence and microscopy
Cryo-sections were fixed in cold acetone, dried and
blocked for non-specific fluorescence with Fc Receptor
Block and Background Buster (Innovex Biosciences,
Richmond, CA, USA). Sections were stained with the in-
dicated antibodies and subsequently stained with DAPI
(Invitrogen). Digital images were taken using an Olym-
pus BX51 with a Planapo20/0.7 or Planapo40/0.95 ob-
jective, a Roper Coolsnap HQ camera and Metamorph
software (Molecular Devices, Sunnyvale, CA, USA). Im-
ages were acquired using the same exposures for anti-
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Figure 1 Isolation protocols for the eight antigen-presenting cell populations studied. (a) Workflow representing the protocol for isolation
of APCs from skin, vagina and blood. (b) Gating strategy for FACS sorting of vaginal APC subsets (upper panels), skin DCs (middle panels) or
blood mDCs (lower panels). mDC, myeloid dendritic cell; FCS, fetal calf serum; PBS, phosphate-buffered saline; s, skin; v, vaginal.
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Cells were stained with 7-AAD, anti-HLA-DR-AF700,
anti-Langerin PE or anti-Langerin AF488 (in-house), anti-
CD1c-AF647 (Biolegend) and anti-CD14-eFluor450. Cells
were also stained with anti-LOX-1 (clone 15C4, in-house)
[21], anti-DC-SIGN (BD Biosciences), anti-DC-ASGPR,
[21] anti-DCIR (clone 9E8, in-house), anti-DEC205 (Biole-
gend) and anti-CD40 (BD Biosciences). Phenotypes of va-
ginal APCs were analyzed by flow cytometry on an LSR II
(BD Biosciences).mRNA preparation and hybridization
Total RNA was isolated from cell lysates using the
ArrayPure-Nano-scale RNA Purification Kit (Epicentre,
Madison, WI, USA) according to the manufacturer’s
instructions. RNA (250 ng) from all samples passing
quality control was amplified and labeled using the
TargetAmp™ 2-Round aRNA Amplification Kit 2.0
(Epicentre). Amplified labeled RNA (750 ng) was hy-
bridized overnight to Illumina HT12 V4 beadchips (Illu-
mina, San Diego, CA, USA). Chips were scanned on an
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protocols.
Data pre-processing and batch correction
Raw data were normalized (average) in Genome Studio™
(Illumina). Data were normalized to the median of the 80
samples in Genespring 7.3 (Agilent Technologies, Santa
Clara, CA, USA). To identify technical sources of variabil-
ity, we conducted principal component analysis (PCA)
and principal variance component analysis (PVCA) using
the 27,935 detected genes (Illumina detection P-values
<0.01 in at least 1 of 80 samples). To correct the batch ef-
fect, we conducted Combat correction using the SVA
package from R/Bioconductor [22]. The batch effect’s con-
tribution to variability was removed, as shown by PVCA
in Additional file 2.
Analysis of variance
One-way Welch analysis of variance (ANOVA) was con-
ducted using a P-value cutoff of 0.05 and Benjamini-
Hochberg multiple testing correction.
Principal variance component analysis
The weighted average proportion variance was calculated
with the R/Bioconductor package 'pvca' (version 1.0.0)
[23]. The threshold used for the minimum amount of the
variance explained by the selected principal components
was 0.5.
Results
Eight populations of human antigen-presenting cells
We isolated eight populations of human APCs - four va-
ginal populations, three skin populations and blood
mDCs - and characterized their transcriptional profiles
by microarray. The isolation protocol and sort gating
strategy are presented in Figure 1. The same protocol
was used to isolate cells from the vaginal mucosa and
the skin: i) the biopsy samples were cultured overnight
in the presence of dispase; ii) the skin epidermis and the
dermis, or vaginal epithelium and LP, were separated
and further incubated to allow APC migration into the
media (Figure 1a); and iii) the cells were sorted using the
same antibodies (Figure 1b).
From the vaginal epithelium and LP, vaginal vLCs,
vCD14- DCs, vCD14+ DCs and vMøs were obtained.
HLA-DR- cells were controls. From the skin, epidermal
sLCs, sCD14- DCs and sCD14+ DCs were obtained.
Blood mDC were sorted from buffy coats.
Global transcriptional relationships across APC
populations and tissues
To compare the transcriptional profiles of these eight
APC populations, we first conducted correlation analysis
of all samples starting from the 27,935 transcriptsdetected in this dataset (Illumina detection P-values
<0.01 in at least 1 of 80 samples). The matrix in Figure 2a
displays correlations between samples within and across
cell populations and tissues. sLCs and mDCs showed
patterns distinct from all other populations. Dermal
sCD14- and sCD14+ DCs displayed high correlation,
highlighting their transcriptional similarities. Although
the four vaginal APC subsets displayed significant vari-
ability within each population, vLCs correlated more
strongly with vCD14- DCs, while vCD14+ DCs corre-
lated more strongly with vMøs. This observation is in
agreement with the previously described functional simi-
larities between these two pairs of human vaginal APC
subsets [5].
One-way ANOVA identified 9,955 differentially expressed
transcripts (DETs) between the eight APC populations.
These transcripts were hierarchically clustered and repre-
sented as a heatmap in Figure 2b. To identify the known
experimental parameters that most influenced sample clus-
tering, we conducted PVCA. Taking into account tissue, cell
population, and the interaction between these two parame-
ters, we found that the tissue of origin (skin, vagina or
blood) explained the largest proportion of variance (0.37),
followed by cell population (0.17) (Figure 2c). This observa-
tion was further substantiated using PCA (Figure 2d) and
hierarchical clustering (Additional file 3), where samples pri-
marily clustered by tissue. In the vagina, vLCs and vCD14-
DCs clustered together, while vCD14+ DCs and vMøs
formed another cluster, consistent with the correlation levels
observed between these APC subsets in Figure 2a.
Finally, Tukey’s test following ANOVA identified the
transcripts differentially regulated between populations in a
pair-wise fashion. The results are displayed as a heatmap
representing the number of DETs between each population
pair (Figure 2e). The most distant populations were vMøs
and sLCs (694 DETs), while vLCs and vCD14- DCs were
the most similar (only 5 DETs).
Thus, unsupervised analysis identified relative tran-
scriptional similarities and differences between the eight
APC populations considered, highlighting the import-
ance of the tissue of origin in determining global tran-
scriptional fingerprints.
Tissue- and population-specific transcriptional profiles
To further understand the differences in transcriptional pro-
files between these eight APC populations, we conducted
additional variance analysis. The 9,955 DETs resulting from
the ANOVA (Figure 2b) were filtered based on the P-value
for each population. For each subset, we selected transcripts
that were differentially expressed from the mean of all sam-
ples (P < 0.05), requiring that the P-value for all populations
other than the one of interest remains greater than 0.05
(Figure 3a). This approach also enables the identification of
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Figure 2 Unsupervised analysis highlights transcriptional relationships between antigen-presenting cell populations. (a) Correlation
matrix of samples obtained from the 27,935 transcripts detected in the dataset (Illumina detection P-values <0.01 in at least 1 of 80 samples). (b)
Hierarchical clustering (Pearson correlation) of the 9,955 transcripts differentially expressed between the eight populations studied. (c) Histogram
representing the weighted average proportion variance for tissue, cell population and the interactive term of these two parameters measured by
PVCA. (d) Principal component analysis of the 80 samples analyzed, classified according to the normalized expression of the 9,955 transcripts
identified above. The samples are colored either by tissue (left panel) or cell population (right panel). Both three-dimensional (upper panels) and
two-dimensional PCA are displayed (lower panels). (e) Heatmap representing the results of Tukey’s test. The values plotted represent the number
of transcripts differentially expressed between each pair of cell populations.
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http://genomemedicine.com/content/6/11/98compared with others, such as genes specific for skin (P <
0.05 in sLCs, sCD14- DCs and sCD14+ DCs), vagina (P <
0.05 in vLCs, vCD14- DCs, vCD14+ DCs and vMøs) or LCs
(P < 0.05 in sLCs and vLCs), for example. The results of this
analysis are displayed in Figure 3b, with the P-value for each
population displayed on the right panel of the heatmap. To
focus on over-expressed transcripts, we additionally filteredsignificant genes for a minimum 1.5-fold increase compared
with the normalized mean across samples.
In this fashion, we identified 151 transcripts specific-
ally over-expressed in sLCs, 118 in sCD14- DCs, 5 in
sCD14+ DCs, 15 in vLCs, 12 in vCD14- DCs, 6 in
vCD14+ DCs, 82 in vMøs and 121 in mDCs. In addition,
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Figure 3 Analysis of variance identifies population-specific transcripts. (a) Heatmap describing the filtering method applied to identify
population-specific transcripts. (b) Heatmap representing the normalized expression of transcripts specifically over-expressed in each APC
population studied, as well as groups of populations or tissues. P-values are represented in purple gradient on the right.
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http://genomemedicine.com/content/6/11/98and 28 in vaginal APCs. Population-specific transcripts
are represented as knowledge-based Ingenuity Pathway
Analysis (IPA) networks in Additional files 4 and 5.
These groups of genes can act as potential molecular
biomarkers for the APC subsets considered herein.Two major vaginal APC transcriptional phenotypes
We then compared the four subsets of vaginal APCs inde-
pendently of other populations. The 42 samples obtained
from vaginal tissue were normalized to the median of all
samples. One-way ANOVA identified 1,559 DETs between
the four populations. Hierarchical clustering supported
the similarity between vLCs and vCD14- DCs as well as
between vCD14+ DCs and vMøs (Figure 4a). Tukey’s test
identified the DETs between vaginal APC populations in a
pairwise fashion (Figure 4b). vMøs and vCD14- DCs were
most distant, with 653 DETs. Only nine genes separated
vLCs and vCD14- DCs. Venn diagram analysis confirmed
that the majority of genes (353 out of 370) differentially
expressed between vLCs and vMøs were also differentially
expressed between vCD14- DCs and vMøs (Figure 4c).
Functionally, vLCs and vCD14- DCs displayed similar cap-
acities to induce T-cell responses [5].The 653 DETs between vCD14- DCs and vMøs are pre-
sented as a heatmap (Figure 4d) and further analyzed for
regulation and enrichment of biologically relevant pathways
by IPA. The predicted regulatory pathways were repre-
sented as circular networks with the transcripts on the cir-
cumference and the transcription factors and cytokines
enriched by in silico IPA network growth in the center. The
157 transcripts over-expressed in vCD14- DCs included
transcripts related to antigen processing and presentation
(LAMP3, HLA-DOB, HLA-DQB1, CIITA, CD1E), DC
maturation (CCR7), interaction with lymphocytes (VCAM-
1) [24] and Th2 activation molecules (TNFSF4 (OX40L),
CCL22) (Figure 4e) [25,26]. These transcripts were con-
nected in silico to molecules involved in the activation of T-
helper cells, including CD40LG, IL5, IL13 and IFNG. In
addition, vCD14- DCs expressed increased levels of the
regulatory T cell (Treg) inducer IDO1 [27], the anti-
inflammatory gene RAMP1 [28] and B-cell activation and
survival factor TNFSF13B [29]. Conversely, the 496
transcripts over-expressed in vMøs were enriched for
Mø markers (CD14, CD163, CD68) and innate pro-
inflammatory molecules (IL8, PLAUR, cathepsins, Fc
receptors, CXCLs, complement and bacterial Toll-like
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Figure 4 (See legend on next page.)
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(See figure on previous page.)
Figure 4 Transcriptional analysis of vaginal antigen-presenting cell subsets. (a) Hierarchical clustering (Pearson correlation) of the 1,559 transcripts
differentially expressed (one-way ANOVA, P< 0.05, Benjamini-Hochberg correction) between the four vaginal APC populations. (b) Heatmap representing the
results of Tukey’s test conducted after ANOVA. (c) Venn diagram of the 653 and 370 transcripts differentially expressed between vCD14- DCs and vMøs and
between vLCs and vMøs. (d) Hierarchical clustering (Pearson correlation) of the 653 transcripts differentially expressed between vCD14- DCs and vMøs. (e) IPA
network analysis for the 157 transcripts over-expressed in vCD14- DCs compared with vMøs. (f) IPA network analysis for the 496 transcripts over-expressed in
vMøs compared with vCD14- DCs. (g) Bar chart representing the IPA canonical pathway enrichment in vCD14- DCs and vMøs. (h) Bar charts representing the
batch-corrected expression values for selected transcripts over-expressed in vCD14- DCs (top row) or vMøs (bottom row).
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http://genomemedicine.com/content/6/11/98to major inflammatory mediators, including IL1A/B,
NFKB/RELA, TNF and colony stimulating factors CSF1
and CSF2 (Figure 4f ). In addition, vMøs expressed in-
creased levels of IL24 transcript, which encodes for a
cytokine known to promote Th1 polarization [30].
These observations were further supported by IPA ca-
nonical pathway and Gene Ontology biological process
enrichment analyses, which identified the Th2-inducing
OX40 signaling pathway as the most highly enriched
pathway in genes over-expressed in vCD14- DCs. Several
innate and inflammatory pathways were enriched in
vMøs (Figure 4g; Figure S3a in Additional file 6), includ-
ing signaling of IL8, TLR and the triggering receptor
expressed on myeloid cells type-1 (TREM-1), which is
an orphan receptor of the immunoglobulin superfamily
induced by the DAP12 signaling pathway. TREM-1 acti-
vation induces the production of inflammatory cyto-
kines, including IL8, MCP/CCL2 and TNF [31]. The
same observations were made when comparing vLCs
and vMøs (Figure S3b in Additional file 6; Additional
file 7). The batch-corrected expression of transcripts
linked to Th2 induction (TNFSF4, CCL22, CIITA, HLA-
DOB) and inflammation (IL8, IL24, PLAUR, PYCARD),
which are over-expressed in CD14- vaginal APCs and
CD14+ vaginal APCs complemented the observations
made at the pathway level (Figure 4h).
Altogether, these data suggest that vLCs and vCD14-
DCs have a transcriptional phenotype oriented towards
the activation of Th2 cells. This provides a molecular
basis for our previous finding that these populations can
differentiate allo-naive CD4+ T cells into Th2 cells
in vitro [5]. In addition, increased expression of IDO and
RAMP1 in vCD14- DCs and vLCs suggests that these
cells may also have regulatory functions. In contrast, the
transcriptionally similar vCD14+ DCs and vMøs are
geared for innate immunity, inflammation, pathogen-
associated molecular patterns (PAMPs) detection and
Th1-type responses.
A regulatory profile in skin epidermal Langerhans cells
We then conducted a similar analysis in skin DC popu-
lations, independently of other APC subsets. We identi-
fied 3,228 DETs between sLCs, sCD14- DCs and sCD14+
DCs (Figure 5a). Hierarchical clustering of these tran-
scripts highlighted the transcriptional distance betweensLCs and sCD14- DCs, the latter population being more
similar to sCD14+ DCs. This contrasts with vaginal
APCs, where vLCs and vCD14- DCs were almost identi-
cal transcriptionally (Figure 4a). Thus, the main separ-
ation in the skin results from the epidermal and dermal
compartmentalization, which was not the case in the va-
ginal mucosa (Figure 4). This was further confirmed by
Tukey’s test, which identified 544 DETs between sLCs
and sCD14- DCs and 466 between sLCs and sCD14+
DCs (Figure 5b). Of these, 317 transcripts were shared
between the two comparisons as shown by Venn
diagram (Figure 5c). Only six transcripts representing
four genes were differentially expressed between all three
comparisons (CXCL1, CXCL5, IL24 and CTSL1;
Additional file 8), which could serve as molecular bio-
markers of these three skin DC subsets.
The 544 DETs between sLCs and sCD14- DCs were
clustered (Figure 5d) and subjected to IPA network and
pathway enrichment analysis. The regulatory network of
the 242 transcripts over-expressed in sLCs included
sterol regulatory element-binding proteins SREBF1 and
SREBF2, two molecules involved in the regulation of
lipid and cholesterol biosynthesis [32] (Figure 5e). The
transcripts enriched in sLCs were enriched for choles-
terol biosynthesis, as well as glutaryl-CoA degradation,
tryptophan degradation and the melavonate pathway,
three pathways linked to T-cell regulation by DCs and
involving the regulatory enzyme indolamine 2,3-dioxy-
genase (INDO/IDO) [27] (Figure 5g). The transcripts
encoding this protein (INDO and IDO1) were over-
expressed in sLCs, while both dermal CD14- and CD14+
DC subsets were enriched in pro-inflammatory mole-
cules IL1B, TNFA and IL23A (Figure 5h).
Conversely, the 302 transcripts over-expressed in
sCD14- DCs (and sCD14+ DCs) included innate immunity
and pro-inflammatory genes (CCLs, CXCLs, SERPINAs,
IL8, IL23A), and were connected to major inflammatory
cytokines (IL1, IFNG, TNF) and transcription factors
(NFKB, RELA) (Figure 5f). As observed for vCD14+ DC
populations, these transcripts were enriched for pathways
linked to innate immunity and inflammation, including
TREM1 signaling, Mø function and IL17 signaling
(Figure 5g; Additional file 9). This was supported by Gene
Ontology enrichment analysis, which identified inflamma-
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Figure 5 (See legend on next page.)
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Figure 5 Transcriptional analysis of skin dendritic cell subsets. (a) Hierarchical clustering (Pearson correlation) of the 3,228 transcripts differentially
expressed (one-way ANOVA, P< 0.05, Benjamini-Hochberg correction) between the three skin DC populations. (b) Heatmap representing the results of
Tukey’s test conducted after ANOVA. (c) Venn diagram of the three comparisons conducted during the post hoc test. (d) Hierarchical clustering (Pearson
correlation) of the 544 transcripts differentially expressed between sLCs and sCD14- DCs. (e) IPA network analysis for the 242 transcripts over-expressed in
sLCs compared with sCD14- DCs. Molecules are colored according to their fold change in the condition represented compared with the median. (f) IPA
network analysis for the 302 transcripts over-expressed in sCD14- DCs compared with sLCs. (g) Bar chart representing the IPA canonical pathway
enrichment in sLCs and sCD14- DCs. (h) Bar charts representing the batch-corrected expression values for selected transcripts over-expressed in sLCs
(top row) or sCD14- DCs (bottom row).
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http://genomemedicine.com/content/6/11/98amongst the biological processes enriched in sCD14- DCs
(Additional file 10).
Taken together, the three skin DC subsets displayed
two major transcriptional phenotypes that were segre-
gated by the tissue compartment in which they localized.
Epidermal sLCs displayed a regulatory phenotype, while
dermal sCD14- and sCD14+ DCs displayed an innate im-
munity and pro-inflammatory phenotype similar to that
of vaginal CD14+ APCs.
Vaginal dendritic cells versus skin dendritic cells
To further understand the effect of tissue origin on tran-
scriptional phenotype, we compared DC populations from
vagina and skin. To this end, LC, CD14- DC and CD14+
DC samples from vagina and skin were recombined into a
single experiment and analyzed. vMøs were not included
as their skin counterparts were not accessible. One-way
ANOVA identified 6,599 DETs between the six popula-
tions (Figure 6a). Tukey’s test identified DETs in a pairwise
fashion, with the greatest transcriptional difference be-
tween sLCs and vCD14+ DCs (Figure 6b). The DETs be-
tween sLCs and vLCs, sCD14- and vCD14- DCs and
sCD14+ and vCD14+ DCs are clustered and represented
as heatmaps in Figure 6c.
Venn diagrams identified overlap between the three com-
parisons, as well as DETs in each comparison (Figure 6d).
These included 12 transcripts over-expressed in vagina and
8 transcripts over-expressed in skin in all three compari-
sons (Figure 6e), providing a 20 transcript tissue-specific
signature. As a non-APC tissue control, transcriptional pro-
files for vaginal HLA-DR- cells were also obtained (seven
biological replicates). Among the genes enriched in vaginal
tissue, LTB (lymphotoxin-β) and CD24 were also over-
expressed in HLA-DR- vaginal cells. Lymphotoxin signaling
is important for the development and maintenance of
lymphoid tissue structure, including Peyer’s patches in the
mucosa [33], and is also associated with the ability of mu-
cosal DCs to regulate IgA production by plasma cells [34].
CD24 expressed on DCs acts as a co-stimulatory molecule
for Th17 cells [35] and cytotoxic T lymphocyte responses
[36]. In addition, AXL, a member of the TAM receptor
tyrosine kinase family involved in regulation of TLR and
interferon-induced inflammatory cascades, was selectively
over-expressed in HLA-DR+ vaginal populations. sDCswere enriched for CYTIP, a molecule involved in DC motil-
ity [37] that also displays regulatory functions in mouse
DCs [38]. The DETs in each of the three comparisons are
hierarchically clustered and displayed in Additional files 11,
12 and 13.
We also compared vDCs and sDCs by t-test, grouping
cells by tissue, and including HLA-DR- vaginal cells as
control. We found 1,007 DETs between sDCs and vDCs,
with 640 over-expressed in sDCs and 367 over-
expressed in vDCs (Figure S11a in Additional file 14).
The transcripts over-expressed in sDCs were enriched
for metabolic processes, including metabolism of nitro-
gen compounds and RNA, while the transcripts over-
expressed in vDCs were enriched for immune-related
biological processes, including defense response, phago-
cytosis and cell adhesion (Figure S11b in Additional file
14). We further compared the 367 transcripts over-
expressed in vDCs (compared with sDCs) to HLA-DR-
vaginal cells. Of these, 88 were similarly expressed, 123
were under-expressed and 156 were over-expressed in
HLA-DR- vaginal cells. The genes over-expressed in va-
ginal HLA-DR- cells compared with vaginal HLA-DR+
cells included many transcripts expressed in epithelial
cells, such as keratins, defensins and serpinases, with
network connections to inflammatory cytokines such as
IL17, IL1 and type I and II interferon (Figure S11c in
Additional file 14). The 123 transcripts over-expressed
in HLA-DR+ DCs were enriched for CLEC10A, OLR1,
cathepsins, CD1s and Mø markers such as CD163.
Globally, tissue comparisons yielded more transcripts
linked to immune response and inflammation in vDCs,
while sDCs exhibited a metabolism fingerprint.
Pattern-recognition receptor expression in vaginal
APC subsets
To further understand the phenotype of vaginal APC sub-
sets and the immunology of the human vagina, we analyzed
the expression levels of pattern-recognition receptors,
including C-type lectin-like receptors (LLRs) and TLRs, and
compared them with those of skin and blood DC subsets.
Vaginal APC populations expressed increased levels of
CLEC5A, CLEC4F, CLEC4A, CLEC2B, CLEC16A, OLR1,
CLEC10A, and CD209 compared with other LLRs
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Figure 6 Comparison between vaginal and skin dendritic cell subsets. (a) Hierarchical clustering (Pearson correlation) of the 6,559 transcripts
differentially expressed (one-way ANOVA, P < 0.05, Benjamini-Hochberg correction) between the six skin and vaginal DC populations. (b) Heatmap
representing the results of Tukey’s test conducted after ANOVA. (c) Hierarchical clustering of the transcripts obtained in inter-tissue comparison
(skin versus vagina) for each pair of DC subsets. (d) Venn diagram of the transcripts obtained in inter-tissue comparison (skin versus vagina) for
each pair of DC subsets. (e) Hierarchical clustering of the 20 transcripts from the overlap in (d).
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http://genomemedicine.com/content/6/11/98phenotypes of vaginal APCs (Figure 4), vLCs were close to
vCD14- DCs while vCD14+ DCs were close to vMøs in
terms of expression levels of the eight LLRs. Both CD209
and OLR1 were highly expressed especially in vCD14+
DCs and vMøs. vCD14+ DCs and vMøs expressed higher
levels of CD209 and OLR1 than sCD14+ DCs. In addition,
CLEC5A was expressed in vLCs but not sLCs. Similarly,
vCD14- DCs expressed CLEC4F, while sCD14- DCs
showed no or minimal expression of CLEC4F. Compared
with vaginal APCs and sDCs, blood mDCs expressed in-
creased levels of CLEC2B, CLEC10A, and CLEC12A, but
decreased levels of CD209, CLEC5A, and CLEC4F. Fur-
thermore, batch-corrected expression analysis identified
three additional lectins that were over-expressed in
vCD14+ DCs and vMøs: CLEC2B, CLEC5A and LGALS8
(Additional files 15 and 16). Conversely, only CLEC16A
was over-expressed in vLCs and vCD14- DCs.In contrast to LLRs, vDC subsets and their skin coun-
terparts expressed similar levels of TLRs, MDA5, and
RIG-I (Additional file 17). However, CD14+ populations,
particularly vMøs, expressed increased levels of bacterial-
sensing TLRs (TLR2, TLR5, TLR6, TLR8).
We next assessed the expression levels of LLRs and other
receptors that have been previously tested for vaccines
targeting in vivo DCs [21,39-43]. CD209 and CLEC10A,
OLR1, and CLEC4A, but not CLEC13B, were detected in all
four vaginal APC subsets with increased expression of
CD209, CLEC10A, and CLEC4A in vMøs (Figure 7a;
Additional file 18). The expression of DC-SIGN, DC-
ASGPR, and LOX-1 was confirmed on vCD14+ DCs and
vMøs at the protein level by flow cytometry (Figure 7b) and
in situ by immunofluorescence (Figure 7c). LOX-1 was also
expressed at low levels on vCD14- DCs (Figure 7b,c). Tran-
scriptional levels of CD207 were low in all vaginal APC



































































































































































































Figure 7 Surface receptor expression on vaginal antigen-presenting cells. (a) Transcriptional levels of CD209 (DC-SIGN), OLR1 (LOX-1), CLEC10A
(DC-ASGPR) and CLEC4A (DCIR) in the four vaginal APC populations. Bar charts represent the mean± standard deviation of batch-corrected expression data.
(b) Fluorescence-activated cell sorting (FACS) analysis of CD209, DC-ASGPR, LOX-1, DCIR, DEC-205 and CD40 expression on the surface of vaginal APC subsets.
Vaginal cell suspensions were stained with the indicated antibodies and gated as described in Figure 1b. Gray histograms represent isotype controls. Data are
representative of 10 donors. (c) Frozen tissue sections were stained for (i) DC-SIGN, DC-ASGPR or LOX-1 (green), CD1c (light blue); and CD14 (red); or (ii) DCIR
(red), CD1c (light blue) and CD14 (green); or (iii) DEC-205 (green), CD1c (light blue) and CD207 (red) (DAPI (dark blue), ×20, the horizontal bar represents 100 μm).
Data are representative of four to eight independent experiments (left panel) or combined (right panel). Isotype controls are presented in Additional file 18.
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http://genomemedicine.com/content/6/11/98subsets, despite detectable protein levels on the surface of
vLCs (Figure 1b), as previously reported [5,6]. DC-ASGPR
was detected in a few vLCs and approximately 50% (49.06 ±
25) of vCD14- DCs (Figure 7b, c). DCIR was detected on all
APC subsets by immunofluorescence and flow cytometry
(Figure 7c). DEC-205 was detected on LCs and some sub-
mucosal DCs by immunofluorescence and flow cytometry,
despite undetectable transcriptional expression. CD40 tran-
scriptional levels were low in all vaginal APC subsets (not
shown), although CD40 was detected on all migrated vaginal
APC subsets by flow cytometry (Figure 7b).
Expression of inflammatory mediators in vaginal APC
subsets
Finally, we analyzed the expression of cytokines, chemo-
kines and their receptors. The results are summarized in
Additional file 19. Dermal DCs and vaginal CD14+ pop-
ulations displayed increased levels of neutrophil che-
moattractants CXCL1, CXCL2 and CXCL5 (Additional
file 20), as well as pro-inflammatory cytokines IL1A,
IL1B, IL24, TNF and IL8 (Additional file 21). All sDC
populations expressed higher levels of IL23A, while vaginal
populations displayed increased IL32, and mDCs displayed
increased IL12A and CXCL10, suggesting tissue-specific
capacities to polarize T-helper responses. Dermal DCs
expressed higher levels of IL1R1, IL1R2 and IL18R, which
may polarize them to respond to products of the inflamma-
some, while vMøs were enriched in IL10RB and IL17RA,
two receptors involved in defense against extracellular path-
ogens. Interestingly, sLCs expressed increased levels of
several CKLF-like MARVEL transmembrane domain-
containing proteins (CMTM4, CMTM6, CMTM8), which
constitute a novel family of chemokine receptors about
which little is known.
Discussion
We report the first transcriptional characterization of
four human vaginal APC subsets by microarray. We
compared these transcriptional profiles with those of
three skin DC populations and blood mDCs. Combining
unsupervised, pathway-level and transcript-level ana-
lyses, we identified tissue- and population-specific tran-
scripts, as well as whole molecular pathways that
potentially control the biological functions of APCs in
the human vaginal mucosa and the skin [3,5,44]. This
database of 87 microarray samples obtained from human
vagina, skin and blood provides an important resource
to understand tissue-specific immunity and guide the ra-
tional development of microbial vaccines.
Unsupervised analysis enabled the measurement of the
transcriptional separation between APC populations in
an unbiased fashion. vLCs were similar to vCD14- DCs,
while vCD14+ DCs were similar to vMøs, suggesting that
CD14 expression can be used to differentiate betweentwo main APC groups with distinct fingerprints. The
global transcriptional distance between populations is
probably best expressed by PCA (Figure 2d), and can be
confirmed by Tukey’s post hoc test (Figure 2e). Tukey’s
post hoc test is a stringent test identifying pairwise differ-
ences within the populations considered for ANOVA.
Because of the stringency of the test, the number of
genes differentially expressed between two populations
is affected by the number of samples and variability
within groups. vCD14+ DCs and vLCs displayed a higher
degree of variability across donors than vMøs, thereby
explaining lower numbers of genes detected, despite
more similar profiles between vCD14+ DCs and Møs. In
fact, both CD14+ populations presented an innate
inflammatory profile with increased expression of
pattern-recognition receptors, consistent with less ma-
ture populations. The CD14- populations were enriched
for T-cell co-stimulation and antigen-presentation tran-
scripts, consistent with a more mature profile. The tran-
scriptional proximities between CD14- APCs and CD14+
APCs are concordant with the functional capacities we
previously described, where vLCs and vCD14- DCs
polarize CD4+ T cells towards the Th2 phenotype [5]. In
this context, the increase in OX40L (TNFSF4), CCL22
and MHC class II-related transcripts (CIITA and HLA-
DRs) in CD14- APC populations suggests an OX40L-
dependent mechanism of Th2 induction. Interestingly,
sDCs did not show the same transcriptional separation
based on expression of CD14. Their transcriptional
phenotype separated mainly based on physical location,
where the two dermal populations displayed a profile
distinct from that of sLCs. Finally, it is important to note
that the individual APC populations we describe in this
manuscript may contain additional levels of heterogen-
eity. For example, we have previously shown that both
CD14- and CD14+ LP-DCs could be further separated
into two subpopulations based on CD1a expression
[5,6]. Further studies, such as single-cell RNA sequen-
cing of populations of interest, are warranted to further
characterize the heterogeneity of these populations.
When comparing transcriptional fingerprints between
tissues, we observed that sDCs were enriched for meta-
bolic pathways, while vDCs were enriched for immune-
related networks. Although the female genital tract is
considered an immune-privileged site [10-12], this ob-
servation, along with the data from our previous study,
[5] supports that DCs in the human vaginal mucosa can
elicit immune responses, as previously observed in mice
[45]. These findings have important implications for the
rational design of mucosal vaccines against sexually
transmitted pathogens.
In addition, the transcriptional profiling of skin and va-
ginal APCs enabled us to formulate new hypotheses on
the mechanisms controlling some of the known functions
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INDO, a molecule involved in DC-dependent induction of
Tregs, were significantly overexpressed in sLCs compared
with other sDCs (Figure 5h). These data support recent
studies showing the induction of Tregs by sLCs in the ab-
sence of foreign antigen stimulation [44,46]. Therefore, these
factors should be considered in the development of vaccines
that elicit potent immunity in the vaginal mucosa.
The differences observed between tissues may also be
influenced by the composition of the microbiome from
each tissue. The vaginal microbiome is highly enriched in
lactobacilli [47], while the skin microbiome is enriched for
staphylococci and actinobacteria [15,48]. In fact, it was
shown that microbiota can influence immunity by trigger-
ing expression of C-type lectins [49] or controlling the
Th1/Th2 balance [50]. The interactions between the
microbiome and DC functions in different tissues and the
outcomes of immune responses at steady state and during
infections need to be further studied.
Finally, we used these data to formulate testable hy-
potheses regarding the expression of various receptors
on the surface of each vaginal APC population. As vagi-
nal CD14+ cells displayed a more immature and innate
phenotype, it was logical to find that transcripts for re-
ceptors that could be used as targeting molecules for
antibody-conjugated vaccines (such as C-type lectins)
were globally enriched in these populations, particularly
in vMøs. Of the known lectins, only CLEC16A was tran-
scriptionally enriched in vLCs and vCD14- DCs. Inter-
estingly, this putative immuno-receptor, which belongs
to a gene complex involving CIITA and SOCS1, is linked
to autoimmune disorders such as multiple sclerosis and
rheumatoid arthritis [51,52].
Our study has several limitations. First, the majority of
skin samples were obtained from individuals with high
body mass index undergoing cosmetic surgeries. There-
fore, we cannot exclude that the lipid-rich environment
of the skin affects the transcriptional profiles observed.
Although inflamed vaginal tissues were excluded in this
study, a large fraction of samples were from patients
who underwent pelvic surgeries. These challenges are
common in the study of human immunology using sur-
gical tissue samples. Another major limitation is the
in vivo relevance of the data generated in vitro. The data
generated with human tissue samples still needs to be
validated in vivo. In this respect, the surface biomarkers
of the vaginal APC subsets characterized in this study
are important findings and clinically relevant because we
can now design mucosal vaccines that can target specific
receptors that are expressed on specific subsets of the
vaginal APCs. Vaccines targeting the proper subsets of
DCs in conjunction with appropriate adjuvants have
proven an efficient strategy to elicit potent immunity
[21,40-43].To conclude, this study provides new insights on the
molecular mechanisms that regulate the functions of vagi-
nal APC subsets. The identification of population-specific
biomarkers combined with an understanding of major
functional characteristics of each APC population in the
vaginal mucosa will be important for the development of
targeted vaccines against sexually transmitted pathogens,
as well as cancers, in the female genital tract.
Conclusions
We generated a transcriptional dataset of 87 microarray
samples spanning eight APC populations across human va-
gina, skin and blood. Complementary transcript and
network-level analyses of these data, combined with in situ
immunohistochemistry of major pattern recognition recep-
tors in the vaginal mucosa, permitted the phenotypic and
functional characterization of these populations. By com-
paring vagina, skin and blood, we found that APC genomic
fingerprints are significantly influenced by the tissue of ori-
gin, revealing tissue-specific microenvironments. Nonethe-
less, CD14+ APCs from both vagina and skin are geared
towards innate immunity and pro-inflammatory responses,
whereas CD14- DCs, particularly sLCs, vLCs, and vCD14-
DCs, display both Th2-inducing and regulatory phenotypes.
These data will help the further characterization of human
tissue APC lineages and will guide the design of mucosal
vaccines against sexually transmitted pathogens.
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the NCBI Gene Expression Omnibus [53] (GEO series ac-
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and batch-corrected expression datasets are presented.
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